検索
Edgewise Therapeutics Inc
EWTXウォッチリストに追加
36.810USD
+1.990+5.72%
終値 06/18, 16:00（ET）15分遅れの株価
3.96B時価総額
損失額直近12ヶ月PER
株主
更新時刻: Mon, May 11
更新時刻: Mon, May 11
株主統計
種類
株主統計
株主統計
比率
OrbiMed Advisors, LLC
14.42%
RA Capital Management, LP
9.69%
Baker Bros. Advisors LP
6.11%
Paradigm BioCapital Advisors LP
6.08%
BlackRock Institutional Trust Company, N.A.
4.99%
他の
58.71%
株主統計
株主統計
比率
OrbiMed Advisors, LLC
14.42%
RA Capital Management, LP
9.69%
Baker Bros. Advisors LP
6.11%
Paradigm BioCapital Advisors LP
6.08%
BlackRock Institutional Trust Company, N.A.
4.99%
他の
58.71%
種類
株主統計
比率
Hedge Fund
26.58%
Investment Advisor
25.01%
Investment Advisor/Hedge Fund
22.62%
Private Equity
18.57%
Venture Capital
16.08%
Research Firm
4.77%
Pension Fund
0.83%
Sovereign Wealth Fund
0.70%
Individual Investor
0.46%
機関投資家保有株
更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
423
124.09M
115.41%
-4.77M
2025Q4
387
119.80M
108.62%
--
2025Q3
392
119.88M
108.70%
-25.05K
2025Q2
397
119.92M
109.42%
+13.50M
2025Q1
381
106.67M
114.89%
-2.71M
2024Q4
360
100.40M
111.45%
-3.06M
2024Q3
330
102.86M
113.45%
-343.49K
2024Q2
288
102.77M
111.98%
+3.64M
2024Q1
262
99.10M
100.16%
+5.54M
2023Q4
235
80.75M
106.84%
+11.50M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
OrbiMed Advisors, LLC
15.52M
14.47%
--
--
Dec 31, 2025
RA Capital Management, LP
10.43M
9.72%
--
--
Dec 31, 2025
Baker Bros. Advisors LP
6.58M
6.13%
-730.00K
-9.99%
Dec 31, 2025
Paradigm BioCapital Advisors LP
6.54M
6.1%
+371.08K
+6.01%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
5.37M
5%
+288.25K
+5.68%
Dec 31, 2025
Novo Holdings A/S
5.35M
4.99%
--
--
Dec 31, 2025
Braidwell LP
5.21M
4.86%
--
--
Dec 31, 2025
Janus Henderson Investors
4.57M
4.26%
-412.48K
-8.28%
Dec 31, 2025
Invus Public Equities Advisors, LLC
4.53M
4.22%
+632.89K
+16.24%
Dec 31, 2025
Perceptive Advisors LLC
4.46M
4.16%
+662.08K
+17.44%
Dec 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Neuroscience and Healthcare ETF
3.27%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.09%
State Street SPDR S&P Pharmaceuticals ETF
1.71%
ALPS Medical Breakthroughs ETF
0.81%
Virtus LifeSci Biotech Clinical Trials ETF
0.8%
First Trust Multi-Manager Small Cap Opportunities ETF
0.55%
iShares U.S. Pharmaceuticals ETF
0.5%
ProShares Ultra Nasdaq Biotechnology
0.33%
Optimize Strategy Index ETF
0.26%
iShares Health Innovation Active ETF
0.25%
詳細を見る
iShares Neuroscience and Healthcare ETF
比率3.27%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率2.09%
State Street SPDR S&P Pharmaceuticals ETF
比率1.71%
ALPS Medical Breakthroughs ETF
比率0.81%
Virtus LifeSci Biotech Clinical Trials ETF
比率0.8%
First Trust Multi-Manager Small Cap Opportunities ETF
比率0.55%
iShares U.S. Pharmaceuticals ETF
比率0.5%
ProShares Ultra Nasdaq Biotechnology
比率0.33%
Optimize Strategy Index ETF
比率0.26%
iShares Health Innovation Active ETF
比率0.25%
